Tumor cells generally increase glucose metabolism through glycolysis and pentose phosphate pathways to meet rapid cell proliferation’s bioenergy and biosynthesis requirements, and 6-phosphofructo-2-kinase (PFKFB2) is a key enzyme for glycolysis (31). The gene discussed is PFKFB2; the disease is neoplasm.